Skip to main content

Infliximab Biosimilars & Signal Identification

Basic Details
Status
Complete
Last Updated
Wednesday, July 22, 2026
Original Posting Date
Health Outcome(s)
signal identification
Purpose
Signal Identification
Meets requirements of FD&C Act Sec 505(o) prior to requiring a PMR
No
Analytic Code Link(s) (1)
Outcome Monitoring Following Infliximab Biosimilar Product Use: An Active Comparator Signal Identification Analysis
Result(s) (1)
Outcome Monitoring Following Infliximab Biosimilar Product Use: An Active Comparator Signal Identification Analysis
Related Publication(s) and/or Presentation(s) (1)
Presentation: Safety Signal Identification for Infliximab Biosimilars: An Exact-and Propensity Score-Matched Cohort Study Using Variable Probability Tree-Based Scan Statistics